4E Therapeutics
About:
4E Therapeutics is a neuroscience company that develops therapies for chronic neuropathic pain.
Website: https://4etherapeutics.com
Top Investors: National Institutes of Health
Description:
4E Therapeutics is developing an innovative therapy for chronic neuropathic pain and is also at the forefront of discovering and developing compounds to treat migraine and acute pain. Neuropathic pain is a serious unmet medical need. They make an effort to regulate the activity of pain-sensing neurons in the peripheral nervous system.
Total Funding Amount:
$7.2M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Austin, Texas, United States
Founded Date:
2019-01-01
Founders:
Craig Benson, Joe Price, Ted Price
Number of Employees:
11-50
Last Funding Date:
2021-11-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai